SES vs. OCUL

Last updated Apr 1, 2026

Compare and contrast key facts about SES AI Corp (SES) and Ocular Therapeutix, Inc. (OCUL).

Performance

SES vs. OCUL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SES AI Corp (SES) and Ocular Therapeutix, Inc. (OCUL). The values are adjusted to include any dividend payments, if applicable.

SES vs. OCUL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
SES SES AI Corp	-46.56%	-17.81%	19.67%	-41.90%	-68.34%	-7.44%
OCUL Ocular Therapeutix, Inc.	-30.23%	42.15%	91.48%	58.72%	-59.68%	-64.18%

Fundamentals

Market Cap SES : $318.34M OCUL : $1.89B
EPS SES : -$0.22 OCUL : -$1.38
PS Ratio SES : 15.18 OCUL : 31.49
PB Ratio SES : 1.48 OCUL : 2.89
Total Revenue (TTM) SES : $21.00M OCUL : $51.95M
Gross Profit (TTM) SES : $11.31M OCUL : $45.25M
EBITDA (TTM) SES : -$76.30M OCUL : -$258.96M

Returns By Period

In the year-to-date period, SES achieves a -46.56% return, which is significantly lower than OCUL's -30.23% return.

SES

• 1D: 4.83%
• 1M: -41.34%
• YTD: -46.56%
• 6M: -42.40%
• 1Y: 84.75%
• 3Y*: -31.17%
• 5Y*: -37.37%
• 10Y*: —

OCUL

• 1D: 14.46%
• 1M: -5.26%
• YTD: -30.23%
• 6M: -27.54%
• 1Y: 15.55%
• 3Y*: 17.14%
• 5Y*: -13.42%
• 10Y*: -1.51%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SES vs. OCUL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SES

SES Risk / Return Rank: 68
SES Sharpe Ratio Rank: 68
SES Sortino Ratio Rank: 73
SES Omega Ratio Rank: 70
SES Calmar Ratio Rank: 64
SES Martin Ratio Rank: 63

OCUL

OCUL Risk / Return Rank: 50
OCUL Sharpe Ratio Rank: 50
OCUL Sortino Ratio Rank: 53
OCUL Omega Ratio Rank: 52
OCUL Calmar Ratio Rank: 47
OCUL Martin Ratio Rank: 48

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SES vs. OCUL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SES AI Corp (SES) and Ocular Therapeutix, Inc. (OCUL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SES	OCUL	Difference
Sharpe ratio Return per unit of total volatility	0.76	0.21	+0.55
Sortino ratio Return per unit of downside risk	1.71	0.91	+0.80
Omega ratio Gain probability vs. loss probability	1.21	1.11	+0.10
Calmar ratio Return relative to maximum drawdown	1.04	0.20	+0.84
Martin ratio Return relative to average drawdown	2.29	0.52	+1.78
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SES vs. OCUL - Sharpe Ratio Comparison

The current SES Sharpe Ratio is 0.76, which is higher than the OCUL Sharpe Ratio of 0.21. The chart below compares the historical Sharpe Ratios of SES and OCUL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	SES	OCUL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.76	0.21	+0.55
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.33	-0.17	-0.16
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.02	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.34	-0.05	-0.29

Correlation

The correlation between SES and OCUL is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SES vs. OCUL - Dividend Comparison

Neither SES nor OCUL has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

SES vs. OCUL - Drawdown Comparison

The maximum SES drawdown since its inception was -97.58%, roughly equal to the maximum OCUL drawdown of -95.19%. Use the drawdown chart below to compare losses from any high point for SES and OCUL.

Drawdown Indicators

	SES	OCUL	Difference
Max Drawdown Largest peak-to-trough decline	-97.58%	-95.19%	-2.39%
Max Drawdown (1Y) Largest decline over 1 year	-74.08%	-57.29%	-16.79%
Max Drawdown (5Y) Largest decline over 5 years	-97.58%	-89.14%	-8.44%
Max Drawdown (10Y) Largest decline over 10 years	—	-90.94%	—
Current Drawdown Current decline from peak	-91.36%	-80.43%	-10.93%
Average Drawdown Average peak-to-trough decline	-64.84%	-76.58%	+11.74%
Ulcer Index Depth and duration of drawdowns from previous peaks	33.59%	22.71%	+10.88%

Volatility

SES vs. OCUL - Volatility Comparison

SES AI Corp (SES) has a higher volatility of 50.27% compared to Ocular Therapeutix, Inc. (OCUL) at 19.52%. This indicates that SES's price experiences larger fluctuations and is considered to be riskier than OCUL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SES	OCUL	Difference
Volatility (1M) Calculated over the trailing 1-month period	50.27%	19.52%	+30.75%
Volatility (6M) Calculated over the trailing 6-month period	86.11%	58.02%	+28.09%
Volatility (1Y) Calculated over the trailing 1-year period	112.01%	75.47%	+36.54%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	113.43%	78.73%	+34.70%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	112.49%	80.20%	+32.29%

Financials